首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Thrombosis Journal

Thrombosis Journal杂志,由BioMed Central出版,于2003年创刊,1 issue/year,出版语言English,ISSN:1477-9560,E-ISSN:1477-9560。

投稿咨询
Thrombosis Journal
Thrombosis Journal
Thrombosis Journal
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
2.7
CiteScore
3.8
期刊收录
SCI、SCIE

Thrombosis Journal(中文译名:《血栓形成杂志》),ISSN:1477-9560,EISSN:1477-9560,是BioMed Central出版的国际性学术期刊,创刊于2003年,以1 issue/year形式稳定发行,2026年总发文量约131篇。该刊采用OA开放访问,学科归属为Medicine - Hematology。该刊是医学、血液学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.7,2025年期刊CiteScore为3.8,2025年期刊自引率约3.7%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Thrombosis Journal长期聚焦医学、血液学及相关产业的技术应用前沿,平均审稿周期16 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、血液学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAJapan、England、GERMANY (FED REP GER)、France、Netherlands、Italy等为核心发文国家与地区;MAASTRICHT UNIVERSITYMCMASTER UNIVERSITY、UNIVERSITY OF LONDON、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、BAYER AG、UNIVERSITY OF AMSTERDAM、CHAIM SHEBA MEDICAL CENTER等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
HEMATOLOGY 血液学 PERIPHERAL VASCULAR DISEASE 外周血管病
3区 3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
HEMATOLOGY 血液学 PERIPHERAL VASCULAR DISEASE 外周血管病
3区 3区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEMATOLOGY 血液学 PERIPHERAL VASCULAR DISEASE 外周血管病
4区 4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 46 / 103

55.8

学科:PERIPHERAL VASCULAR DISEASE SCIE Q2 48 / 100

52.5

学科:HEMATOLOGY SCIE Q2 39 / 103

62.62

学科:PERIPHERAL VASCULAR DISEASE SCIE Q2 48 / 100

52.5

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 40 / 97

59.3

学科:PERIPHERAL VASCULAR DISEASE SCIE Q2 37 / 96

62

学科:HEMATOLOGY SCIE Q2 39 / 97

60.31

学科:PERIPHERAL VASCULAR DISEASE SCIE Q2 39 / 96

59.9


中国学者近期发文

1
Association of novel inflammation markers derived from high-sensitivity C-reactive protein with anemia: a cross-sectional study based on NHANES 2015-201

Author:Peng, Jing; Wan, Li; Tan, Jing; Zeng, Linli

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00851-y

2
Thrombolytic therapy in vertebrobasilar dolichoectasia patients with acute posterior circulation cerebral infarction: a case series analysi

Author:Han, Qi; Zhu, En-Bo; Jin, Guang-lin; Lin, Ming-Quan; Qu, Lin-Zhuo; Guan, Hong-Jian; Che, Hui-ying

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00849-6

3
Sepsis induced coagulopathy (SIC): is it monolithic

Author:Wang, Lu; Zhou, Xiang

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00845-w

4
Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS databas

Author:Liu, Zhenqi; Ye, Xu

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00840-1

5
High thrombotic burden in severe Chinese wAIHA patients: a single-center retrospective stud

Author:Xiong, Jing; Wan, Li; Chen, Huixin; Hu, Bicheng

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00843-y

6
Recurrent venous thrombosis in an adolescent male with CBS mutation and persistent antiphospholipid antibody positivity: a case repor

Author:Wang, Yuebing; Li, Ru; Li, Chun

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-025-00820-x

7
Optimal timing of anticoagulation therapy for venous thromboembolism prevention after intracranial hemorrhag

Author:Ni, Qian; Wang, Qinghe; Qi, Jialin; Cai, Jing; Qiao, Tong; Wang, Baoyan

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00836-x

8
Efficacy, safety, and influencing factors of AngioJet mechanical thrombectomy versus catheter-directed thrombolysis in the treatment of acute lower limb deep vein thrombosi

Author:Chen, Min; Le, Changyun; Lin, Hai; Wang, Liang

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-025-00814-9

9
Thromboembolic events associated with antiangiogenic monoclonal antibodies: a disproportionality analysis from FDA adverse event reporting system (FAERS) databas

Author:Zhou, Hong; Su, Yanzhao; Song, Jianrong; Zhen, Lan

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00829-w

10
4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational statu

Author:Zhang, Xueya; Guo, Xizhe

Journal: THROMBOSIS JOURNAL. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12959-026-00828-x


在线咨询

Thrombosis Journal

国际简称:THROMB J参考译名:血栓形成杂志

年发文量:131 CiteScore:3.8 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:84.73%

杂志社联系方式:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Thrombosis Journal